UBS Group’s NLS Pharmaceutics NLSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.4K | Sell |
14,982
-10,755
| -42% | -$31.2K | ﹤0.01% | 6588 |
|
|
2025
Q1 | $39.6K | Buy |
25,737
+17,445
| +210% | +$26.9K | ﹤0.01% | 6465 |
|
|
2024
Q4 | $17.5K | Buy |
8,292
+3,573
| +76% | +$7.54K | ﹤0.01% | 6736 |
|
|
2024
Q3 | $23.9K | Sell |
4,719
-1,174
| -20% | -$5.95K | ﹤0.01% | 6058 |
|
|
2024
Q2 | $51.2K | Buy |
+5,893
| New | +$51.2K | ﹤0.01% | 5527 |
|
|
2023
Q3 | – | Sell |
-85
| Closed | -$3.75K | – | 8565 |
|
|
2023
Q2 | $3.75K | Buy |
+85
| New | +$3.75K | ﹤0.01% | 6525 |
|
|
2023
Q1 | – | Sell |
-246
| Closed | -$12.7K | – | 8830 |
|
|
2022
Q4 | $12.7K | Buy |
+246
| New | +$12.7K | ﹤0.01% | 7049 |
|
|
2022
Q3 | – | Sell |
-381
| Closed | -$9K | – | 9518 |
|
|
2022
Q2 | $9K | Buy |
381
+116
| +44% | +$2.74K | ﹤0.01% | 7119 |
|
|
2022
Q1 | $15K | Sell |
265
-54
| -17% | -$3.06K | ﹤0.01% | 6789 |
|
|
2021
Q4 | $14K | Sell |
319
-1,243
| -80% | -$54.6K | ﹤0.01% | 7221 |
|
|
2021
Q3 | $156K | Buy |
1,562
+1,514
| +3,154% | +$151K | ﹤0.01% | 4454 |
|
|
2021
Q2 | $6K | Buy |
+48
| New | +$6K | ﹤0.01% | 7347 |
|